Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology Review
Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology Overview
Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented and future developments are discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO. The book will serve as an authentic and essential source of information for radiotherapists, oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion or laboratory medicine and pharmacologists.
Available at Amazon Check Price Now!
Related Products
- Neoplasmatic Design (Architectural Design)
- Lewis.Tsurumaki.Lewis: Opportunistic Architecture
- Bioreboot: The Architecture of R&sie{n}
- Unit 20: Bartlett School of Architecture
- The Function of Ornament
Customer Reviews
*** Product Information and Prices Stored: Aug 16, 2010 15:20:13
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.